Anavex reports Q3 EPS (14c), consensus (16c)
PremiumThe FlyAnavex reports Q3 EPS (14c), consensus (16c)
4M ago
AVXL Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AVXL Upcoming Earnings Report: What to Expect?
4M ago
Anavex Life Sciences Ends Equity Offering Program
Premium
Company Announcements
Anavex Life Sciences Ends Equity Offering Program
4M ago
Anavex announces expansion of leadership team
PremiumThe FlyAnavex announces expansion of leadership team
6M ago
Anavex sees cash runway of approximately four years
Premium
The Fly
Anavex sees cash runway of approximately four years
6M ago
Anavex reports Q2 EPS (13c) vs. (17c) last year.
Premium
The Fly
Anavex reports Q2 EPS (13c) vs. (17c) last year.
6M ago
Anavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71
PremiumThe FlyAnavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71
8M ago
SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors
9M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100